Concepedia

Thomas Cope

TC

57

Publications

4.8K

Citations

33

H-Index

2006

Active since

Affiliations

University of Cambridge(Current)

MRC Cognition and Brain Sciences Unit

Medical Research Council

University College London

Cambridge University Hospitals NHS Foundation Trust

Thomas Cope is an author at University of Cambridge specializing in medicine, neuroscience, and social sciences.

Top concepts

MedicineNeuroscienceNeurologySocial SciencesDementiaNeuropathologyNeurodegenerationAlzheimer's DiseaseNeurodegenerative DiseasesHealth

Publications per year

2006–2025

57

Publications

57

Azithromycin in patients admitted to hospital with COVID-19 (RECOVERY): a randomised, controlled, open-label, platform trial

Eugenia Abaleke, Mustafa Abbas, Sadia Abbasi et al. · The Lancet · 2021 · 555 citations · Full text

Long Covid, Antimicrobial Stewardship, Antibiotics +7

Convalescent plasma in patients admitted to hospital with COVID-19 (RECOVERY): a randomised controlled, open-label, platform trial

Obbina Abani, Ali Abbas, Fatima Abbas et al. · The Lancet · 2021 · 516 citations · Full text

Casirivimab and imdevimab in patients admitted to hospital with COVID-19 (RECOVERY): a randomised, controlled, open-label, platform trial

Obbina Abani, Ali Abbas, Fatima Abbas et al. · The Lancet · 2022 · 382 citations · Full text

Covid-19 Pandemic, Antiviral Therapy, Clinical Trials +3

Age at symptom onset and death and disease duration in genetic frontotemporal dementia: an international retrospective cohort study

Katrina Moore, Jennifer Nicholas, Murray Grossman et al. · The Lancet Neurology · 2019 · 296 citations · Full text

Disease Duration, Neurodegenerative Diseases, Alzheimer's Disease +15

Aspirin in patients admitted to hospital with COVID-19 (RECOVERY): a randomised, controlled, open-label, platform trial

Obbina Abani, Ali Abbas, Fatima Abbas et al. · The Lancet · 2021 · 289 citations · Full text

Rows per page

1–5 of 57